Akari Therapeutics And Peak Bio Announce Merger Of Equals; Exchange Is Expected To Result In Implied Equity Ownership In The Combined Company Of Approximately 50% For Akari Shareholders And Approximately 50% For Peak Stockholders
Akari Therapeutics And Peak Bio Announce Merger Of Equals; Exchange Is Expected To Result In Implied Equity Ownership In The Combined Company Of Approximately 50% For Akari Shareholders And Approximately 50% For Peak Stockholders
Akari Therapeutics和Peak Bio宣佈對等合併；交易所預計將使合併後的公司的隱含股權爲Akari股東約50％，Peak股東的隱含股權約爲50％
Akari Therapeutics And Peak Bio Announce Merger Of Equals; Exchange Is Expected To Result In Implied Equity Ownership In The Combined Company Of Approximately 50% For Akari Shareholders And Approximately 50% For Peak Stockholders
Akari Therapeutics和Peak Bio宣佈對等合併；交易所預計將使合併後的公司的隱含股權爲Akari股東約50％，Peak股東的隱含股權約爲50％
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。